相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of the effects of different potent adjuvants on enhancing the immunogenicity and cross-protection by influenza virus vaccination in young and aged mice
Noopur Bhatnagar et al.
ANTIVIRAL RESEARCH (2022)
Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin
Bo Ryoung Park et al.
SCIENTIFIC REPORTS (2021)
Neutralizing Antibodies Targeting the Conserved Stem Region of Influenza Hemagglutinin
Sabari Nath Neerukonda et al.
VACCINES (2020)
The continued advance of vaccine adjuvants - 'we can work it out'
Derek T. O'Hagan et al.
SEMINARS IN IMMUNOLOGY (2020)
Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay
Wonil Chae et al.
VACCINE (2019)
Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants
Pengfei Wang et al.
ACS INFECTIOUS DISEASES (2019)
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shuting Shi et al.
VACCINE (2019)
Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
Ki-Hye Kim et al.
VIROLOGY (2019)
Vaccine Adjuvants Derivatized from Momordica Saponins I and II
Pengfei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant
Pengfei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles
Young-Tae Lee et al.
VIROLOGY (2019)
MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine
Eun-Ju Ko et al.
ANTIVIRAL RESEARCH (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
Young-Tae Lee et al.
PLOS ONE (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Dante J. Marciani
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
From discovery to licensure, the Adjuvant System story
Nathalie Garcon et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
Srinivasa Reddy Bonam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
Margherita Coccia et al.
NPJ VACCINES (2017)
Vaccine adjuvants: smart components to boost the immune system
Rakesh Bastola et al.
ARCHIVES OF PHARMACAL RESEARCH (2017)
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O'Hagan et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Robyn Marty-Roix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Vaccine adjuvants as potential cancer immunotherapeutics
Burcu Temizoz et al.
INTERNATIONAL IMMUNOLOGY (2016)
A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus
Yu-Na Lee et al.
JOURNAL OF IMMUNOLOGY (2016)
Synthesis and Evaluation of QS-21-Based Immunoadjuvants with a Terminal-Functionalized Side Chain Incorporated in the West Wing Trisaccharide
Pengfei Wang et al.
JOURNAL OF ORGANIC CHEMISTRY (2016)
Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells
Eun-Ju Ko et al.
JOURNAL OF VIROLOGY (2016)
A Randomized, Controlled Safety, and Immunogenicity Trial of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-Positive Indian Adults
Nagalingeswaran Kumarasamy et al.
MEDICINE (2016)
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
A. L. Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing
Hwee-Ing Ng et al.
SCIENTIFIC REPORTS (2016)
The avian influenza vaccine Emerflu. Why did it fail?
Barnaby E. Young et al.
EXPERT REVIEW OF VACCINES (2015)
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
Himal Lal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
Geert Leroux-Roels et al.
VACCINE (2015)
Cancer vaccine adjuvants - recent clinical progress and future perspectives
Abid H. Banday et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2015)
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Alberta Di Pasquale et al.
VACCINES (2015)
The amphiphilic nature of saponins and their effects on artificial and biological membranes and potential consequences for red blood and cancer cells
Joseph H. Lorent et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
Min-Chul Kim et al.
ANTIVIRAL RESEARCH (2013)
Synthesis of QS-21-Based Immunoadjuvants
Pengfei Wang et al.
JOURNAL OF ORGANIC CHEMISTRY (2013)
Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
Najoua Dendouga et al.
VACCINE (2012)
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
Govind Ragupathi et al.
EXPERT REVIEW OF VACCINES (2011)
Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus
Jae-Min Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials
Christian L. Tielemans et al.
VACCINE (2011)
Vaccine adjuvants: A priority for vaccine research
Ali M. Harandi et al.
VACCINE (2010)
Unmet needs in modern vaccinology Adjuvants to improve the immune response
Geert Leroux-Roels
VACCINE (2010)
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
Pierre Vandepapeliere et al.
VACCINE (2008)
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults
P Vandepapelière et al.
VACCINE (2005)
分享论文
